以患者为中心、理论指导的调查设计识别临床试验参与的障碍与驱动因素
研究提出以行为理论驱动的可适配方法设计试验前调查,而非统一问卷。基于理论域框架(TDF)检索文献并为加拿大乳腺癌网络与亨廷顿病协会分别制定调查,经发声思维访谈迭代修改,两群体分别识别出38项(覆盖12个TDF域)与47项(覆盖13个TDF域)参与相关障碍/驱动因素。
要点
- 以TDF为框架的定制调查可更全面识别试验参与障碍与驱动因素。
- 不同患者群体识别出的条目数与覆盖域不同,需按临床领域定制。
- 发声思维访谈迭代修改可提升调查清晰度与可用性。
核心结论
- 以患者为中心、理论指导的方法较现有工具能识别更全面的试验参与障碍与驱动因素,且更易跨情境适配。
研究设计与样本
- 方法学文章:基于理论域框架(TDF,14个域、逾100个构念)检索文献后,为加拿大乳腺癌网络与加拿大亨廷顿病协会分别制定定制调查。
- 对两组患者进行发声思维访谈,迭代修改条目并征询相关障碍/驱动因素意见。
主要发现
- 访谈加拿大乳腺癌网络8名有乳腺癌病史女性(48–65岁)与亨廷顿病协会11名社区成员(9名女性,26–70岁)。
- 乳腺癌组在12个TDF域内识别38项参与相关障碍/驱动因素。
- 亨廷顿病组在13个TDF域内识别47项条目。
临床怎么用
- 试验招募前可按TDF域定制调查,识别本领域特异的参与障碍与驱动因素。
- 已知域特异性障碍后,可据此制定更具体的招募策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Despite clear evidence showing that many clinical trials fail or are delayed because of poor patient recruitment, there is surprisingly little empirically supported guidance for trialists seeking to optimize their trial recruitment strategies. We propose that the challenges of recruitment can be better understood and addressed by thinking of research participation as one or more behaviors, subject to the same forces as other human behaviors. In this article, we describe an adaptable, behavioral theory-driven approach for designing pretrial surveys of the barriers and drivers relevant to trial participation. Instead of proposing a single survey instrument intended to be used uniformly across many situations, we propose that tailored surveys be informed by a common comprehensive, theory-guided development approach that ensures all domains potentially guiding participation are considered. STUDY DESIGN AND SETTING: We used the Theoretical Domains Framework (TDF), which organizes over 100 constructs known to be associated with behavior and behavior change into 14 domains that describe determinants of professional and patient health behaviors, to inform the development of tailored surveys about barriers to and drivers of clinical trial participation. After searching the literature for barriers and drivers to trial recruitment relevant to each of the TDF domains, we developed separate surveys for members of two national health charities (Canadian Breast Cancer Network, Huntington Society of Canada) to exemplify how the approach can be adapted across settings. We conducted think-aloud interviews with members of each group to maximize the clarity and usability of the surveys, elicited opinions about which barriers/drivers were relevant for each patient group, and identified additional barriers/drivers. Interviews proceeded iteratively with changes incorporated into subsequent interviews. Here, we describe our two target patient groups, as well as our process of modifying, adding, and deleting barrier/driver items for each group and across theoretical domains. RESULTS: We interviewed 8 women with a history of breast cancer from the Canadian Breast Cancer Network (48-65 year old) and 11 Huntington Disease community members (9 women) from the Huntington Society of Canada (26-70 year old). After the iterative development interviews, the breast cancer group had identified 38 barriers/drivers thought relevant to their participation in clinical trials across 12 TDF domains. The Huntington group identified 47 items across 13 TDF domains. CONCLUSION: Our patient-focused and theory-guided approach was able to identify a more comprehensive range of barriers to and drivers of trial participation than existing published tools. Our approach is also more broadly adaptable than such tools, in that it uses a theoretical framework and in-depth piloting to generate a set of items tailored to each specific clinical area, rather than a single set of items intended to be applicable to all situations. This theory-guided approach also enables more specific recruitment strategies to be developed once domain-specific barriers are known, potentially optimizing participation for a given trial and helping build a cumulative evidence of barriers/drivers and strategies for addressing them.
引用
- Brehaut JC, Carroll K, Presseau J, et al. A patient-focused, theory-guided approach to survey design identified barriers to and drivers of clinical trial participation. J Clin Epidemiol. 2020. PMID: 33338563. doi:10.1016/j.jclinepi.2020.12.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。